RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
about
Targeted Delivery Systems for Molecular Therapy in Skeletal DisordersPolysaccharide-based Noncovalent Assembly for Targeted Delivery of Taxol.Theragnostic ultrasound using microbubbles in the treatment of prostate cancerNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.ICAM-1-Targeted Liposomes Loaded with Liver X Receptor Agonists Suppress PDGF-Induced Proliferation of Vascular Smooth Muscle Cells.Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy studyDevelopment of individualized anti-metastasis strategies by engineering nanomedicinesDoxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.Targeting tumor metastases: Drug delivery mechanisms and technologies.Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line.Natural Non-Mulberry Silk Nanoparticles for Potential-Controlled Drug Release.Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphomaReview peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues.Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences.RGD-modified lipid disks as drug carriers for tumor targeted drug delivery.Multifunctional platinum-based nanoparticles for biomedical applications.Liposome-targeted delivery for highly potent drugs.Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma.Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs.Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.Amperometric Detection of Conformational Change of Proteins Using Immobilized-Liposome Sensor System.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.Antidepressant-like effects of tetrahydroxystilbene glucoside in mice: Involvement of BDNF signaling cascade in the hippocampus.Construction of a PLGA based, targeted siRNA delivery system for treatment of osteoporosis.Induction of Chondrogenic Differentiation of Human Mesenchymal Stem Cells by Biomimetic Gold Nanoparticles with Tunable RGD Density.Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer.Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain.Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalization.Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.Self-Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma.Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects.Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
P2860
Q26752158-0A90F287-74C6-4F7F-A6CA-34E7180A9EC5Q27301912-672AAE04-D2B8-45F0-90E0-6F7DA461FA6AQ28067216-3127446B-2906-4E5F-AF05-1796678BAF03Q30354652-23C6BFCB-C257-4956-8CA4-1D239CE23D07Q33633564-7B0FEFB2-4C40-45EA-BEB4-99FB1AB59B75Q33829590-279B86D2-811F-4568-8A1F-6E632582A56BQ35967474-F0308C3F-9F0F-44F9-82A6-E2DD815780D0Q36106734-C86C5B8D-40F9-4DD7-A83C-2DE4B65F9742Q36137279-CCBEA2A3-D2EC-42C4-B383-03F1F00861E6Q36557855-65FA4DCD-EFCA-4D2E-BAE9-B50A656CAA50Q37168978-A765CA1F-FF87-4FB9-8A38-8FAE5DFAF850Q37534610-C76C195B-7A8D-439D-9E2F-82FB0C7A6012Q37642601-9D05F97E-1E29-400F-8989-172BC5348517Q38502588-11CC7B03-4CC8-490E-9145-C25573E73ACAQ38756785-44873FAB-52E1-4145-8D0C-D08F3D96E3F7Q38784335-10776B76-D9A1-4EA2-A8F1-24D076F13F6FQ38786704-84ACEF7C-143D-44E6-B016-F8531B98A5D1Q38812240-08ED2272-80A8-429C-B556-993F3DF4B943Q39171223-0FE3E704-50CB-4035-9CD0-1A5D0B4E33F2Q40235588-6566FCF9-CF83-4089-9F52-9F7ECB667C9AQ45064375-415B24F1-ED0E-4511-906D-CFA02BAA448DQ47142933-6281B8EA-59FE-4519-9FFB-7753AC38FF68Q47198758-9A714AE3-5F7C-4173-B04F-FDCD6D75C8FAQ47440128-28061246-EED3-4DE6-8E21-B3E8AC9DC1A5Q47853315-06193C3A-E17B-48D7-80ED-C6969082FA42Q47908177-E1073322-A144-4FA4-8411-D59682300AE4Q48164536-A7A7E813-5EA0-4109-949F-F86FFF8E3997Q48614634-C2E8D311-9F21-4C88-A91C-61DD52ED5723Q49853553-0DF63F3D-3B31-4A96-B009-A4C1A354548CQ50504158-3E04E289-907F-4554-AA3A-2F228D6CC886Q51019313-F79A8960-906E-493A-B74A-67FDDC62A9E7Q55024462-1C44B4A9-370A-49DD-919E-C38B46A1C973Q55061758-3161E21C-604B-4C84-B1C2-17A472A97D89Q55518839-C4CFB556-28AD-4164-AB39-CC88C90AFE4AQ58804947-C9E273C0-059A-491F-94A4-7423C227684F
P2860
RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
RGD peptide conjugated liposom ...... tastasis from prostate cancer.
@en
type
label
RGD peptide conjugated liposom ...... tastasis from prostate cancer.
@en
prefLabel
RGD peptide conjugated liposom ...... tastasis from prostate cancer.
@en
P2093
P1476
RGD peptide conjugated liposom ...... tastasis from prostate cancer.
@en
P2093
Fangfang Wang
Zhongping Chen
P304
P356
10.1016/J.JCONREL.2014.10.012
P407
P577
2014-10-22T00:00:00Z